Why is the vaccine rollout slowing down?
Younger people are proving more reluctant to receive the jab after initial surge in demand
Take-up of Covid-19 vaccines has dropped dramatically in recent days, leading to fears that millions of young people are choosing to go unvaccinated.
Last week, government scientists said the country is “close to maximum take-up” of vaccinations, even though a significant proportion of young people are yet to be protected against the potentially life-threatening illness, reports The Times.
Young adults were the last group to be invited to receive the jab, and after an initial surge in demand, “which NHS bosses compared to the scramble for Glastonbury tickets”, says the Daily Mail, bookings have slowed significantly.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Since vaccinations opened up to all over-18s almost a month ago, just 61% of 18-24-year-olds in England have had their first jab. The figure is only a little higher in the 25 to 29 age group, 67% of whom have had at least one jab, says The Sunday Times. The take-up for those above 40 is well over 90%, according to data from the Office for National Statistics.
‘Inevitable slowdown’
“Among the over-30s, it feels as though everyone who put their hand up first time has been done,” John Roberts, from the Covid-19 Actuaries Response Group, told The Telegraph. He said it was “inevitable” that as the programme reached the end it would slow down.
“If fewer people are putting their hands up in areas where hesitancy is high, we are getting to the point where there are not that many people left to do,” he said. “Then the process of trying to get round to those people on a very manual basis, using whatever techniques they use, is inevitably going to be slow.”
So far, around 46 million people have had a first vaccine dose – about 87% of the adult population – and more than 35 million have had a second. As a nation, the UK “continues to be among those with the highest vaccination rates globally”, reports the BBC.
That may explain why some ministers remain fairly “relaxed” about the slowdown, says The Times. Others argue that the removal of quarantine for the fully vaccinated when going on holiday, or after contact with an infected person, may “act as an incentive to boost take-up”.
But as younger and harder-to-reach groups lag behind, the slowdown will “add to concerns about the scale of a summer wave” when restrictions are lifted on Monday, says the paper.
Vaccine hesitancy in young people
People under 30 are most likely to be vaccine “hesitant”, with 9% of 18-21-year-olds and 10% of 22-25-year-olds expressing a reluctance to take the vaccine, according to the latest ONS figures. Across all age groups, only 4% of adults have indicated hesitancy towards the jab.
The reasons for vaccine hesitancy among young people are varied, and can “originate in people’s backgrounds, philosophical or religious beliefs, or approach to risk”, writes the i newspaper.
But there have been some commonly cited concerns, such as the speed the vaccine was developed and safety concerns over possible side effects, says the paper.
Linda Bauld, professor of public health at the University of Edinburgh, also added that poor experiences with authority could also be putting young people off: “A particular reason there for young people being hesitant is because they distrust authority. Maybe they’ve had an experience with police, they don’t trust the local council or the government, [making them feel] disenfranchised.”
And with young people at lower risk of becoming seriously ill from coronavirus, many feel they simply don’t need the jab, according to Dr Mohammed Razai of the Population Health Research Institute at St George’s University of London.
“The risk of severe disease and deaths from Covid is lower, and perception of risk is lower amongst the younger age group,” he told the i. “That is very obviously causing a complacency. It’s true they’re not high risk relative to others, but they are still at risk of complications like long Covid.”
Some young women also fear the jab could affect their fertility, says the Daily Mail, after the Medicines and Healthcare products Regulatory Agency reported that it had received nearly 4,000 accounts from women in the UK who’d said they’d experienced changes to their periods after the jab.
But the Department of Health says there's “no evidence of an increased risk of menstrual disorders owing to the Covid-19 vaccination”, as the number of reports is extremely low compared to the number of women of child-bearing age in the UK who’ve been vaccinated. The BMJ also said there was “absolutely no evidence” that the jab affected fertility.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Sorcha Bradley is a writer at The Week and a regular on “The Week Unwrapped” podcast. She worked at The Week magazine for a year and a half before taking up her current role with the digital team, where she mostly covers UK current affairs and politics. Before joining The Week, Sorcha worked at slow-news start-up Tortoise Media. She has also written for Sky News, The Sunday Times, the London Evening Standard and Grazia magazine, among other publications. She has a master’s in newspaper journalism from City, University of London, where she specialised in political journalism.
-
7 beautiful towns to visit in Switzerland during the holidays
The Week Recommends Find bliss in these charming Swiss locales that blend the traditional with the modern
By Catherine Garcia, The Week US Published
-
The Week contest: Werewolf bill
Puzzles and Quizzes
By The Week US Published
-
'This needs to be a bigger deal'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
What are Trump's plans for public health?
Today's Big Question From abortion access to vaccine mandates
By Devika Rao, The Week US Published
-
What went wrong at CVS?
Today's Big Question Pharmacy chains are in crisis
By Joel Mathis, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published